相似文献
1
The universe of ANA testing: a case for point-of-care ANA testing.
Auto Immun Highlights. 2017 Dec;8(1):4. doi: 10.1007/s13317-017-0093-6. Epub 2017 Mar 21.
2
Biosensor for total antinuclear antibody determination at the point-of-care.
Biosens Bioelectron. 2016 Sep 15;83:306-11. doi: 10.1016/j.bios.2016.04.048. Epub 2016 Apr 22.
3
Clinical diagnoses associated with a positive antinuclear antibody test in patients with and without autoimmune disease.
BMC Rheumatol. 2023 Aug 7;7(1):24. doi: 10.1186/s41927-023-00349-4.
4
Identification of cyclin A as a molecular target of antinuclear antibodies (ANA) in hepatic and non-hepatic autoimmune diseases.
J Hepatol. 1996 Dec;25(6):859-66. doi: 10.1016/s0168-8278(96)80290-x.
5
[Modern look at the problems of investigation of antinuclear antibodies in systemic lupus erythematosus (literature review).].
Klin Lab Diagn. 2018;63(6):340-348. doi: 10.18821/0869-2084-2018-63-6-340-348.
6
Diagnostic accuracy of ELISA methods as an alternative screening test to indirect immunofluorescence for the detection of antinuclear antibodies. Evaluation of five commercial kits.
Autoimmunity. 2004 Mar;37(2):171-6. doi: 10.1080/08916930310001657010.
7
Antinuclear antibodies (ANA) patterns in paraneoplastic cerebellar degeneration during the course of disease and treatment protocols - A case report.
J Transl Autoimmun. 2020 Jan 31;3:100034. doi: 10.1016/j.jtauto.2020.100034. eCollection 2020.
8
9
Antinuclear antibody (ANA) and ANA profile tests in children with autoimmune disorders: a retrospective study.
Clin Rheumatol. 2000;19(3):200-3. doi: 10.1007/s100670050156.
10
Identification of specific antinuclear antibodies in dogs using a line immunoassay and enzyme-linked immunosorbent assay.
Vet Immunol Immunopathol. 2015 Dec 15;168(3-4):233-41. doi: 10.1016/j.vetimm.2015.10.002. Epub 2015 Oct 9.
引用本文的文献
1
Emerging technologies in autoantibody testing for rheumatic diseases.
Arthritis Res Ther. 2017 Jul 24;19(1):172. doi: 10.1186/s13075-017-1380-3.
本文引用的文献
1
Towards Better Test Utilization - Strategies to Improve Physician Ordering and Their Impact on Patient Outcomes.
EJIFCC. 2015 Jan 27;26(1):15-30. eCollection 2015 Jan.
2
Biosensor for total antinuclear antibody determination at the point-of-care.
Biosens Bioelectron. 2016 Sep 15;83:306-11. doi: 10.1016/j.bios.2016.04.048. Epub 2016 Apr 22.
3
Choosing wisely: Review and commentary on anti-nuclear antibody (ANA) testing.
Autoimmun Rev. 2016 Mar;15(3):272-80. doi: 10.1016/j.autrev.2015.12.002. Epub 2015 Dec 11.
4
Detection of autoantibodies in a point-of-care rheumatology setting.
Auto Immun Highlights. 2013 May 18;4(2):55-61. doi: 10.1007/s13317-013-0052-9. eCollection 2013 Aug.
5
Choosing wisely: the Canadian Rheumatology Association's list of 5 items physicians and patients should question.
J Rheumatol. 2015 Apr;42(4):682-9. doi: 10.3899/jrheum.141140. Epub 2015 Feb 1.
6
Drug-induced lupus.
Expert Opin Drug Saf. 2015 Mar;14(3):361-78. doi: 10.1517/14740338.2015.995089. Epub 2015 Jan 2.
7
Serology of Lupus Erythematosus: Correlation between Immunopathological Features and Clinical Aspects.
Autoimmune Dis. 2014;2014:321359. doi: 10.1155/2014/321359. Epub 2014 Feb 6.
8
Standardization of autoantibody testing: a paradigm for serology in rheumatic diseases.
Nat Rev Rheumatol. 2014 Jan;10(1):35-43. doi: 10.1038/nrrheum.2013.180. Epub 2013 Nov 26.
9
International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies.
Ann Rheum Dis. 2014 Jan;73(1):17-23. doi: 10.1136/annrheumdis-2013-203863. Epub 2013 Oct 14.
10
Reassurance after diagnostic testing with a low pretest probability of serious disease: systematic review and meta-analysis.
JAMA Intern Med. 2013 Mar 25;173(6):407-16. doi: 10.1001/jamainternmed.2013.2762.
Zotero 插件